Literature DB >> 10559240

CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals.

E Garber1, L Su, B Ehrenfels, M Karpusas, Y M Hsu.   

Abstract

X-linked hyper-IgM syndrome is a rare immunodeficiency disorder resulting from mutations in the gene encoding the CD40 ligand (CD154) molecule. These mutations are very heterogeneous, ranging from a single point mutation to a large deletion in the open reading frame. To investigate the molecular mechanisms that are responsible for the functional defect of these mutants, we examined the biochemical properties of 14 hyper-IgM-related CD154 mutant proteins produced by transient expression in COS7 cells. We show that deletion mutants lacking a significant portion of the tumor necrosis factor homologous domain cannot be stably produced. In contrast, point mutants can be detected as oligomers. Surprisingly, gene products of two point mutants, Thr-211 --> Asp and Met-36 --> Arg, can bind to the receptor, CD40. For Thr-211 --> Asp variant, it is comparable to the wild-type protein in its surface expression level, biochemical structure, and functional activities. Thus, it appears that this mutation is a polymorphism of CD154 gene. For Met-36 --> Arg variant, although it is interactive with CD40, it has a much lower surface expression level than wild-type protein. We propose that Met-36 --> Arg mutant represents a prototype of a defective CD154 family whose low cell surface expression of intrinsically active protein is simply insufficient to trigger productive signals through CD40.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559240     DOI: 10.1074/jbc.274.47.33545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  HIGM syndrome caused by insertion of an AluYb8 element in exon 1 of the CD40LG gene.

Authors:  P A Apoil; E Kuhlein; A Robert; H Rubie; A Blancher
Journal:  Immunogenetics       Date:  2006-12-05       Impact factor: 2.846

Review 3.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 4.  The hyper IgM syndrome.

Authors:  R L Fuleihan
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

5.  Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives.

Authors:  M L Prasad; M Velickovic; S A Weston; E M Benson
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

6.  Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature.

Authors:  Boaz Palterer; Lorenzo Salvati; Manuela Capone; Valentina Mecheri; Laura Maggi; Alessio Mazzoni; Lorenzo Cosmi; Nila Volpi; Lucia Tiberi; Aldesia Provenzano; Sabrina Giglio; Paola Parronchi; Giandomenico Maggiore; Oreste Gallo; Alessandro Bartoloni; Francesco Annunziato; Lorenzo Zammarchi; Francesco Liotta
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

7.  Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome.

Authors:  E López-Granados; R Cambronero; A Ferreira; G Fontán; M C García-Rodríguez
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

8.  Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called "milder" mutants.

Authors:  Silvia Danielian; Matias Oleastro; Maria Eva Rivas; Claudio Cantisano; Marta Zelazko
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.542

9.  A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases.

Authors:  Tábata T França; Luiz F B Leite; Tiago A Maximo; Christiane G Lambert; Nuria B Zurro; Wilma C N Forte; Antonio Condino-Neto
Journal:  Front Pediatr       Date:  2018-05-04       Impact factor: 3.418

10.  Residue-Specific Message Encoding in CD40-Ligand.

Authors:  Aditya Yashwant Sarode; Mukesh Kumar Jha; Shubhranshu Zutshi; Soumya Kanti Ghosh; Hima Mahor; Uddipan Sarma; Bhaskar Saha
Journal:  iScience       Date:  2020-08-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.